Anbio Biotechnology Class A Ordinary Shares
NNNN · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,390 | $244 | $244 | $244 |
| - Cash | $6 | $12 | $10 | $10 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,383 | $232 | $234 | $234 |
| Revenue | $5 | $3 | $6 | $4 |
| % Growth | 98.1% | -60% | 60% | – |
| Gross Profit | $5 | $2 | $4 | $2 |
| % Margin | 92.3% | 84.6% | 66.9% | 42.8% |
| EBITDA | $4 | -$1 | $4 | $1 |
| % Margin | 82.8% | -52.4% | 61.5% | 20.2% |
| Net Income | $4 | -$1 | $4 | $1 |
| % Margin | 82.8% | -52.4% | 61.5% | 20.1% |
| EPS Diluted | 0.095 | -0.031 | 0.092 | 0.019 |
| % Growth | 401.9% | -134.1% | 391.4% | – |
| Operating Cash Flow | – | $2 | $1 | -$1 |
| Capital Expenditures | – | -$0 | $0 | -$0 |
| Free Cash Flow | – | $2 | $1 | -$1 |